Latest Articles

Publication Date
Metastatic Carcinomas at the Episiotomy Site: A Systematic Literature Review.

Background/Objectives: Rarely, primary (PriCs) or metastatic (metECs) carcinomas occur in the episiotomy site. Methods: A systematic literature review of metECs was carried out. We reviewed the PRISMA guidelines and the …

Published: Aug. 27, 2025, midnight
New Perspectives on the Use of Resveratrol in the Treatment of Metabolic and Estrogen-Dependent Conditions Through Hormonal Modulation and Anti-Inflammatory Effects.

Estrogen-dependent conditions, such as endometriosis, adenomyosis, lipedema, polycystic ovary syndrome, and breast cancer, are intimately involved with hormonal changes related to estrogen and their receptors. These conditions can be expressed …

Published: Aug. 27, 2025, midnight
Real time alert setup for GTLB performance - Jobs Report & Daily Entry Point Trade Alerts - Newser

Real time alert setup for GTLB performance - Jobs Report & Daily Entry Point Trade Alerts Newser

Published: Aug. 26, 2025, 11:54 p.m.
The Utah Endometriosis Center at St. Mark’s Hospital is open now to serve patients - FOX 13 News Utah

The Utah Endometriosis Center at St. Mark’s Hospital is open now to serve patients FOX 13 News Utah

Published: Aug. 26, 2025, 7:43 p.m.
Leveraging the Role of Microbiome in Endometriosis: Novel Non-Invasive Diagnostic and Therapeutic Approaches - Frontiers

Leveraging the Role of Microbiome in Endometriosis: Novel Non-Invasive Diagnostic and Therapeutic Approaches Frontiers

Published: Aug. 26, 2025, 3:55 p.m.
Why Jemperli and Zejula will be key assets in GSK's India oncology portfolio? - MSN

Why Jemperli and Zejula will be key assets in GSK's India oncology portfolio? MSN

Published: Aug. 26, 2025, 12:50 p.m.
Stanhope Street group serves up support for women facing period poverty - Not Really Here Group

Stanhope Street group serves up support for women facing period poverty Not Really Here Group

Published: Aug. 26, 2025, 12:37 p.m.
Why Jemperli and Zejula will be key assets in GSK’s India oncology portfolio? - Business Today

Why Jemperli and Zejula will be key assets in GSK’s India oncology portfolio? Business Today

Published: Aug. 26, 2025, 12:29 p.m.
GSK Enters India’s Oncology Space With Jemperli & Zejula For Women’s Cancers - BW Healthcare

GSK Enters India’s Oncology Space With Jemperli & Zejula For Women’s Cancers BW Healthcare

Published: Aug. 26, 2025, 8:55 a.m.
GSK Enters India’s Oncology Space With Jemperli & Zejula For Women’s Cancers - BW Healthcare World

GSK Enters India’s Oncology Space With Jemperli & Zejula For Women’s Cancers BW Healthcare World

Published: Aug. 26, 2025, 8:55 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!